Analyst	Recommendation	Action	Price target	Projected	Date
Judah Frommer Morgan Stanley	Buy	Reiterated	USD 14,00	+493,2%	08/12/2026
Yun Zhong Wedbush	Buy	Reiterated	USD 17,00	+620,3%	08/11/2026
Lachlan Hanbury Brown William Blair	Buy	Maintained	-	-	08/11/2026
Tara Bancroft TD Cowen	Buy	Initiated	-	-	06/15/2026
Jonathan Wolleben Citizens JMP	Buy	Maintained	USD 25,00	+959,3%	05/13/2026
Biren Amin Piper Sandler	Hold	Maintained	USD 7,00	+196,6%	03/30/2026
Daniil Gataulin Chardan Capital	Buy	Initiated	USD 19,00	+705,1%	12/23/2025

All values in USD	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	9,13 m	7,16 m	7,57 m	9,02 m
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3,62 m	3,64 m	4,26 m	3,37 m
Operating expense	12,74 m	10,80 m	11,83 m	12,39 m
Total operating expenses	12,74 m	10,80 m	11,83 m	12,39 m
Operating income	-12,74 m	-10,80 m	-11,83 m	-12,39 m
Other non operating income	847,00 k	803,00 k	977,00 k	871,00 k
EBT including unusual items	-11,89 m	-10,00 m	-10,86 m	-11,52 m
EBT excluding unusual items	-11,89 m	-10,00 m	-10,86 m	-11,52 m
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-11,89 m	-10,00 m	-10,86 m	-11,52 m
Net profit margin	-	-	-	-
Earnings per share	-0,64	-0,44	-0,46	-0,48
Interest and investment income	-	-	-	-
Interest expense	-	-	-	-
Net interest expenses	-	-	-	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-12,74 m	-10,79 m	-11,82 m	-12,38 m
Gain or loss from assets sale	-	-	-	-

Ask anything